Matrikines as Mediators of Tissue Remodelling.
Fiche publication
Date publication
avril 2022
Journal
Advanced drug delivery reviews
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DEBELLE Laurent
Tous les auteurs :
Jariwala N, Ozols M, Bell M, Bradley E, Gilmore A, Debelle L, Sherratt MJ
Lien Pubmed
Résumé
Extracellular matrix (ECM) proteins confer biomechanical properties, maintain cell phenotype and mediate tissue repair (via release of sequestered cytokines and proteases). In contrast to intracellular proteomes, where proteins are monitored and replaced over short time periods, many ECM proteins function for years (decades in humans) without replacement. The longevity of abundant ECM proteins, such as collagen I and elastin, leaves them vulnerable to damage accumulation and their host organs prone to chronic, age-related diseases. However, ECM protein fragmentation can potentially produce peptide cytokines (matrikines) which may exacerbate and/or ameliorate age- and disease-related ECM remodelling. In this review, we discuss ECM composition, function and degradation and highlight examples of endogenous matrikines. We then critically and comprehensively analyse published studies of matrix-derived peptides used as topical skin treatments, before considering the potential for improvements in the discovery and delivery of novel matrix-derived peptides to skin and internal organs. From this, we concluded that while the translational impact of matrix-derived peptide therapeutics is evident, the mechanisms of action of these peptides are poorly defined. Further, well-designed, multimodal studies are required.
Mots clés
cosmetic treatment, extracellular matrix, matrikines, peptides, skin ageing, topical therapeutics
Référence
Adv Drug Deliv Rev. 2022 Apr 1;:114240